| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00027 | 1 |